|
DIAPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.116450E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.384000E-02 |
| Normal-vs-Stage2 |
2.320200E-01 |
| Normal-vs-Stage3 |
9.499100E-03 |
| Normal-vs-Stage4 |
1.198790E-03 |
| Stage1-vs-Stage2 |
4.399000E-01 |
| Stage1-vs-Stage3 |
4.910000E-01 |
| Stage1-vs-Stage4 |
1.115380E-01 |
| Stage2-vs-Stage3 |
2.709200E-01 |
| Stage2-vs-Stage4 |
5.553800E-02 |
| Stage3-vs-Stage4 |
3.745600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.416000E-03 |
| Normal-vs-AfricanAmerican |
2.635900E-02 |
| Normal-vs-Asian |
2.998800E-03 |
| Caucasian-vs-AfricanAmerican |
6.635400E-01 |
| Caucasian-vs-Asian |
4.491400E-01 |
| AfricanAmerican-vs-Asian |
9.065200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.566500E-02 |
| Normal-vs-Female |
9.761100E-03 |
| Male-vs-Female |
7.121000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.142800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.420400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.609570E-01 |
| Normal-vs-Age(81-100Yrs) |
1.822220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.750000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.324400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.986000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.144000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.745200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.603800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.387200E-01 |
| Classical-VS-Follicular |
1.11022302462516E-16 |
| Classical-VS-Other |
6.803900E-02 |
| Classical-VS-Normal |
1.94554999999319E-05 |
| Tall-VS-Follicular |
5.75400005420335E-09 |
| Tall-VS-Other |
6.129600E-02 |
| Tall-VS-Normal |
6.374700E-04 |
| Follicular-VS-Other |
2.751400E-01 |
| Follicular-VS-Normal |
1.128110E-02 |
| Other-VS-Normal |
9.570000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.921000E-01 |
| Normal-vs-N1 |
8.810200E-02 |
| N0-vs-N1 |
3.054800E-01 |
|
|
